Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$190.52 - $236.72 $14,860 - $18,464
78 Added 8.39%
1,008 $233,000
Q1 2024

May 03, 2024

SELL
$212.02 - $267.71 $96,893 - $122,343
-457 Reduced 32.95%
930 $200,000
Q4 2023

Feb 06, 2024

BUY
$222.59 - $267.94 $16,694 - $20,095
75 Added 5.72%
1,387 $358,000
Q3 2023

Oct 13, 2023

SELL
$253.3 - $285.89 $529,903 - $598,081
-2,092 Reduced 61.46%
1,312 $337,000
Q2 2023

Aug 03, 2023

BUY
$275.25 - $318.06 $11,285 - $13,040
41 Added 1.22%
3,404 $969,000
Q1 2023

May 08, 2023

SELL
$256.56 - $292.34 $7,440 - $8,477
-29 Reduced 0.85%
3,363 $935,000
Q4 2022

Feb 06, 2023

SELL
$252.44 - $306.72 $133,288 - $161,948
-528 Reduced 13.47%
3,392 $939,000
Q3 2022

Nov 03, 2022

BUY
$194.69 - $268.46 $182,424 - $251,547
937 Added 31.41%
3,920 $1.05 Million
Q2 2022

Jul 29, 2022

BUY
$187.54 - $223.02 $67,139 - $79,841
358 Added 13.64%
2,983 $608,000
Q1 2022

May 10, 2022

BUY
$193.77 - $244.14 $127,888 - $161,132
660 Added 33.59%
2,625 $553,000
Q4 2021

Feb 14, 2022

BUY
$223.92 - $287.77 $3,806 - $4,892
17 Added 0.87%
1,965 $471,000
Q3 2021

Nov 10, 2021

BUY
$282.99 - $369.05 $110,932 - $144,667
392 Added 25.19%
1,948 $551,000
Q2 2021

Aug 09, 2021

BUY
$259.0 - $414.71 $40,145 - $64,280
155 Added 11.06%
1,556 $539,000
Q1 2021

May 05, 2021

BUY
$242.95 - $284.63 $20,893 - $24,478
86 Added 6.54%
1,401 $392,000
Q4 2020

Feb 09, 2021

BUY
$236.26 - $355.63 $310,681 - $467,653
1,315 New
1,315 $322,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Avidian Wealth Solutions, LLC Portfolio

Follow Avidian Wealth Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidian Wealth Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avidian Wealth Solutions, LLC with notifications on news.